Mockingbird is a modern hybrid-indica strain whose specific breeding history is undocumented. Breeders have not publicly confirmed the complete lineage of the variety, though it is recognized as having Fall 97 as a parent. Due to the lack of exhaustive documentation, the origins of this strain remain incomplete, and there is no consensus on its full genetic heritage beyond this primary connection.

The sensory profile of Mockingbird is complex, defined by a broad spectrum of terpenes ranging from caryophyllene and myrcene to limonene, humulene, linalool, bisabolol, nerolidol, beta-pinene, pinene, geraniol, borneol, camphene, terpinolene, and caryophyllene-oxide. Regarding its cannabinoid content, the strain features an estimated THC concentration of 10% alongside an estimated CBD level of 12.73%. These chemical markers contribute to a nuanced flavor and aromatic experience that reflects the strain's diverse terpene array.

In terms of effects, Mockingbird provides a user experience centered on feeling relaxed and focused. It is frequently utilized for the management of pain, stress, and sleep. The plant reaches maturity following a 60-day flowering period, and it is categorized as a moderate-difficulty strain suitable for both indoor and outdoor cultivation environments. The variety is known to produce a high yield, and there are currently no notable offspring recorded for this strain.